Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07246993 · ClinicalTrials.gov registry record · NA

Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms

A NA study of Mild Traumatic Brain Injury and Persistent Post Concussion Syndrome, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07246993: Recruiting NA study of Mild Traumatic Brain Injury and Persistent Post Concussion Syndrome, sponsored by University of Minnesota.

NCT07246993 is a NA study of Mild Traumatic Brain Injury and Persistent Post Concussion Syndrome that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07246993, a NA study of Mild Traumatic Brain Injury and Persistent Post Concussion Syndrome, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mild traumatic brain injury (mTBI).

Primary Outcome

Using score on Penn Cognitive Battery

Conditions Studied

Mild Traumatic Brain Injury Persistent Post Concussion Syndrome

Interventions

  • DEVICE Sham tDCS
  • DEVICE Active tDCS

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-03-05
Est. Completion 2028-01-01
Phase NA
University of Minnesota

966 total trials

What NCT07246993 shows while recruiting

NCT07246993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (86% lower).

The record links to 2 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Sham tDCS is the first listed.

NCT07246993 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07246993 about?

NCT07246993 is a clinical study titled "Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms". This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mil...

What is the current status of trial NCT07246993?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03-05. Estimated completion is 2028-01-01.

What conditions does trial NCT07246993 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Persistent Post Concussion Syndrome.

What interventions are being tested in trial NCT07246993?

The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE).

Who is sponsoring clinical trial NCT07246993?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07246993 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07246993's enrollment target sits among peer trials

30 38th of 43 higher than 6 of 43 other Mild Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07246993

Source: ClinicalTrials.gov NCT07246993, the US trial registry maintained by the National Library of Medicine. NCT07246993 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.